For the millions of people worldwide whose rare disease remains nameless despite genetic testing, the limits of genomic sequencing have long represented a quiet crisis of unanswered suffering. Researchers from Queen Mary University of London, the Berlin Institute of Health at Charité, and Genomics England have now demonstrated that measuring proteins in the blood alongside DNA data can illuminate what the genome alone leaves in shadow — transforming ambiguous genetic findings into genuine diagnoses. The work reminds us that understanding life's blueprint requires not only reading the code, but
Blood protein profiling combined with genomics advances rare disease diagnosis
The research addresses the diagnostic challenges faced by millions of rare disease patients worldwide who lack definitive genetic diagnoses.